Drugs / Andriol Testocaps
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01510847 | Oct 2011 → Sep 2012 | — | Singapore Clinical Research Institute | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Andriol Testocaps | “Drug: Andriol Testocaps” NCT01510847 ↗ |
| Route | Oral | “Subjects enrolled in the study will take two 40mg capsules of oral testosterone in the morning and two 40mg capsules in the evening with meals on both occasions on each day.” NCT01510847 ↗ |